Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3
β Scribed by Hosoe, Shigeto; Brauch, Hiltrud; Latif, Farida; Glenn, Gladys; Daniel, Gambert; Bale, Sherri; Choyke, Peter; Gorin, Michael; Oldfield, Edward; Berman, Arlene; Goodman, Jack; Orcutt, Mary Lou; Hampsch, Krista; Dllisio, John; Modi, William; McBride, Wesley; Anglard, Patrick; Weiss, Gary; Walther, McClellan M.; Linehan, W.Marston; Lerman, Michael I.; Zbar, Berton
- Book ID
- 122479407
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 850 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0888-7543
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Von Hippel-Lindau disease is a heritable tumour syndrome caused by the loss of the function of a tumour suppressor gene on the short arm of human chromosome 3. The interval RAF1-D3S18 (3p25-3p26) has been identified by genetic linkage studies to harbour the von Hippel-Lindau gene. We have constructe
The von Hippel-Lindau gene product (pVHL) interacts with and inhibits the cellular transcription factor elongin. However, the subcellular localization of pVHL has remained uncertain. Naturally occurring pVHL mutants which fail to interact with elongin have been described in patients with VHL disease